2.4.0.6 Html 258 387 1 false 72 0 false 5 false false R1.htm 0000 - Document - Document and Entity Information Sheet http://www.astx.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0010 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.astx.com/role/BalanceSheet CONSOLIDATED BALANCE SHEETS false false R3.htm 0015 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.astx.com/role/BalanceSheetParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 0020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.astx.com/role/StatementOfIncome CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 0030 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Sheet http://www.astx.com/role/StatementOfComprehensiveIncome CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) false false R6.htm 0040 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Sheet http://www.astx.com/role/StatementOfStockholdersEquity CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY false false R7.htm 0050 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.astx.com/role/CashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R8.htm 1010 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.astx.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R9.htm 1020 - Disclosure - Available-for-Sale Securities Sheet http://www.astx.com/role/DisclosureAvailableForSaleSecurities Available-for-Sale Securities false false R10.htm 1030 - Disclosure - Stockholders' Equity Sheet http://www.astx.com/role/DisclosureStockholdersEquity Stockholders' Equity false false R11.htm 1040 - Disclosure - Stock-Based Compensation Sheet http://www.astx.com/role/DisclosureStockBasedCompensation Stock-Based Compensation false false R12.htm 1050 - Disclosure - Acquisition of Astex Therapeutics Limited Sheet http://www.astx.com/role/DisclosureAcquisitionOfAstexTherapeuticsLimited Acquisition of Astex Therapeutics Limited false false R13.htm 1060 - Disclosure - Goodwill and Intangible Assets Sheet http://www.astx.com/role/DisclosureGoodwillAndIntangibleAssets Goodwill and Intangible Assets false false R14.htm 1070 - Disclosure - License and Stock Purchase Agreements with MGI PHARMA, Inc./Eisai Corporation Sheet http://www.astx.com/role/DisclosureLicenseAndStockPurchaseAgreementsWithMgiPharmaIncEisaiCorporation License and Stock Purchase Agreements with MGI PHARMA, Inc./Eisai Corporation false false R15.htm 1080 - Disclosure - Agreements with GlaxoSmithKline Sheet http://www.astx.com/role/DisclosureAgreementsWithGlaxosmithkline Agreements with GlaxoSmithKline false false R16.htm 1090 - Disclosure - Montigen Pharmaceuticals Acquisition Sheet http://www.astx.com/role/DisclosureMontigenPharmaceuticalsAcquisition Montigen Pharmaceuticals Acquisition false false R17.htm 1100 - Disclosure - Nipent Sale Transactions Sheet http://www.astx.com/role/DisclosureNipentSaleTransactions Nipent Sale Transactions false false R18.htm 1110 - Disclosure - AVI BioPharma, Inc./Sarepta Therapeutics, Inc. Sheet http://www.astx.com/role/DisclosureAviBiopharmaIncSareptaTherapeuticsInc AVI BioPharma, Inc./Sarepta Therapeutics, Inc. false false R19.htm 1120 - Disclosure - Commitments and Contingencies Sheet http://www.astx.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies false false R20.htm 1130 - Disclosure - Income Taxes Sheet http://www.astx.com/role/DisclosureIncomeTaxes Income Taxes false false R21.htm 1140 - Disclosure - Employee Benefit Plans Sheet http://www.astx.com/role/DisclosureEmployeeBenefitPlans Employee Benefit Plans false false R22.htm 1150 - Disclosure - Quarterly Financial Data (Unaudited) Sheet http://www.astx.com/role/DisclosureQuarterlyFinancialData Quarterly Financial Data (Unaudited) false false R23.htm 2010 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.astx.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) false false R24.htm 3010 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.astx.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) false false R25.htm 3020 - Disclosure - Available-for-Sale Securities (Tables) Sheet http://www.astx.com/role/DisclosureAvailableForSaleSecuritiesTables Available-for-Sale Securities (Tables) false false R26.htm 3030 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.astx.com/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) false false R27.htm 3040 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.astx.com/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) false false R28.htm 3050 - Disclosure - Acquisition of Astex Therapeutics Limited (Tables) Sheet http://www.astx.com/role/DisclosureAcquisitionOfAstexTherapeuticsLimitedTables Acquisition of Astex Therapeutics Limited (Tables) false false R29.htm 3060 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.astx.com/role/DisclosureGoodwillAndIntangibleAssetsTables Goodwill and Intangible Assets (Tables) false false R30.htm 3120 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.astx.com/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) false false R31.htm 3130 - Disclosure - Income Taxes (Tables) Sheet http://www.astx.com/role/DisclosureIncomeTaxesTables Income Taxes (Tables) false false R32.htm 3150 - Disclosure - Quarterly Financial Data (Unaudited) (Tables) Sheet http://www.astx.com/role/DisclosureQuarterlyFinancialDataTables Quarterly Financial Data (Unaudited) (Tables) false false R33.htm 4010 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.astx.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) false false R34.htm 4011 - Disclosure - Summary of Significant Accounting Policies (Details 2) Sheet http://www.astx.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails2 Summary of Significant Accounting Policies (Details 2) false false R35.htm 4012 - Disclosure - Summary of Significant Accounting Policies (Details 3) Sheet http://www.astx.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails3 Summary of Significant Accounting Policies (Details 3) false false R36.htm 4013 - Disclosure - Summary of Significant Accounting Policies (Details 4) Sheet http://www.astx.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails4 Summary of Significant Accounting Policies (Details 4) false false R37.htm 4014 - Disclosure - Summary of Significant Accounting Policies (Details 5) Sheet http://www.astx.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails5 Summary of Significant Accounting Policies (Details 5) false false R38.htm 4015 - Disclosure - Summary of Significant Accounting Policies (Details 6) Sheet http://www.astx.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails6 Summary of Significant Accounting Policies (Details 6) false false R39.htm 4016 - Disclosure - Summary of Significant Accounting Policies (Details 7) Sheet http://www.astx.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails7 Summary of Significant Accounting Policies (Details 7) false false R40.htm 4017 - Disclosure - Summary of Significant Accounting Policies (Details 8) Sheet http://www.astx.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails8 Summary of Significant Accounting Policies (Details 8) false false R41.htm 4018 - Disclosure - Summary of Significant Accounting Policies (Details 9) Sheet http://www.astx.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails9 Summary of Significant Accounting Policies (Details 9) false false R42.htm 4020 - Disclosure - Available-for-Sale Securities (Details) Sheet http://www.astx.com/role/DisclosureAvailableForSaleSecuritiesDetails Available-for-Sale Securities (Details) false false R43.htm 4030 - Disclosure - Stockholders' Equity (Details) Sheet http://www.astx.com/role/DisclosureStockholdersEquityDetails Stockholders' Equity (Details) false false R44.htm 4040 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.astx.com/role/DisclosureStockBasedCompensationDetails Stock-Based Compensation (Details) false false R45.htm 4050 - Disclosure - Acquisition of Astex Therapeutics Limited (Details) Sheet http://www.astx.com/role/DisclosureAcquisitionOfAstexTherapeuticsLimitedDetails Acquisition of Astex Therapeutics Limited (Details) false false R46.htm 4051 - Disclosure - Acquisition of Astex Therapeutics Limited (Details 2) Sheet http://www.astx.com/role/DisclosureAcquisitionOfAstexTherapeuticsLimitedDetails2 Acquisition of Astex Therapeutics Limited (Details 2) false false R47.htm 4052 - Disclosure - Acquisition of Astex Therapeutics Limited (Details 3) Sheet http://www.astx.com/role/DisclosureAcquisitionOfAstexTherapeuticsLimitedDetails3 Acquisition of Astex Therapeutics Limited (Details 3) false false R48.htm 4053 - Disclosure - Acquisition of Astex Therapeutics Limited (Details 4) Sheet http://www.astx.com/role/DisclosureAcquisitionOfAstexTherapeuticsLimitedDetails4 Acquisition of Astex Therapeutics Limited (Details 4) false false R49.htm 4054 - Disclosure - Acquisition of Astex Therapeutics Limited (Details 5) Sheet http://www.astx.com/role/DisclosureAcquisitionOfAstexTherapeuticsLimitedDetails5 Acquisition of Astex Therapeutics Limited (Details 5) false false R50.htm 4060 - Disclosure - Goodwill and Intangible Assets (Details) Sheet http://www.astx.com/role/DisclosureGoodwillAndIntangibleAssetsDetails Goodwill and Intangible Assets (Details) false false R51.htm 4061 - Disclosure - Goodwill and Intangible Assets (Details 2) Sheet http://www.astx.com/role/DisclosureGoodwillAndIntangibleAssetsDetails2 Goodwill and Intangible Assets (Details 2) false false R52.htm 4062 - Disclosure - Goodwill and Intangible Assets (Details 3) Sheet http://www.astx.com/role/DisclosureGoodwillAndIntangibleAssetsDetails3 Goodwill and Intangible Assets (Details 3) false false R53.htm 4063 - Disclosure - Goodwill and Intangible Assets (Details 4) Sheet http://www.astx.com/role/DisclosureGoodwillAndIntangibleAssetsDetails4 Goodwill and Intangible Assets (Details 4) false false R54.htm 4070 - Disclosure - License and Stock Purchase Agreements with MGI PHARMA, Inc./Eisai Corporation (Details) Sheet http://www.astx.com/role/DisclosureLicenseAndStockPurchaseAgreementsWithMgiPharmaIncEisaiCorporationDetails License and Stock Purchase Agreements with MGI PHARMA, Inc./Eisai Corporation (Details) false false R55.htm 4080 - Disclosure - Agreements with GlaxoSmithKline (Details) Sheet http://www.astx.com/role/DisclosureAgreementsWithGlaxosmithklineDetails Agreements with GlaxoSmithKline (Details) false false R56.htm 4090 - Disclosure - Montigen Pharmaceuticals Acquisition (Details) Sheet http://www.astx.com/role/DisclosureMontigenPharmaceuticalsAcquisitionDetails Montigen Pharmaceuticals Acquisition (Details) false false R57.htm 4100 - Disclosure - Nipent Sale Transactions (Details) Sheet http://www.astx.com/role/DisclosureNipentSaleTransactionsDetails Nipent Sale Transactions (Details) false false R58.htm 4110 - Disclosure - AVI BioPharma, Inc./Sarepta Therapeutics, Inc. (Details) Sheet http://www.astx.com/role/DisclosureAviBiopharmaIncSareptaTherapeuticsIncDetails AVI BioPharma, Inc./Sarepta Therapeutics, Inc. (Details) false false R59.htm 4120 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.astx.com/role/DisclosureCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) false false R60.htm 4121 - Disclosure - Commitments and Contingencies (Details 2) Sheet http://www.astx.com/role/DisclosureCommitmentsAndContingenciesDetails2 Commitments and Contingencies (Details 2) false false R61.htm 4130 - Disclosure - Income Taxes (Details) Sheet http://www.astx.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) false false R62.htm 4131 - Disclosure - Income Taxes (Details 2) Sheet http://www.astx.com/role/DisclosureIncomeTaxesDetails2 Income Taxes (Details 2) false false R63.htm 4140 - Disclosure - Employee Benefit Plans (Details) Sheet http://www.astx.com/role/DisclosureEmployeeBenefitPlansDetails Employee Benefit Plans (Details) false false R64.htm 4150 - Disclosure - Quarterly Financial Data (Unaudited) (Details) Sheet http://www.astx.com/role/DisclosureQuarterlyFinancialDataDetails Quarterly Financial Data (Unaudited) (Details) false false All Reports Book All Reports Element astx_CashProceedsFromSaleOfProductRights had a mix of decimals attribute values: -5 -3. Element astx_GainsLossesOnSalesOfInvestmentsAndAssets had a mix of decimals attribute values: -3 0. Element astx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEstimatedForfeitureRates had a mix of decimals attribute values: 3 4. Element us-gaap_BusinessAcquisitionCostOfAcquiredEntityCashPaid had a mix of decimals attribute values: -5 -3. Element us-gaap_BusinessAcquisitionCostOfAcquiredEntityEquityInterestsIssuedAndIssuable had a mix of decimals attribute values: -5 -3. Element us-gaap_BusinessAcquisitionCostOfAcquiredEntityPurchasePrice had a mix of decimals attribute values: -5 -3. Element us-gaap_CommonStockSharesIssued had a mix of decimals attribute values: -3 0. Element us-gaap_ContributionOfProperty had a mix of decimals attribute values: -3 0. Element us-gaap_LicenseAndServicesRevenue had a mix of decimals attribute values: -3 0. Element us-gaap_ProceedsFromIssuanceOfCommonStock had a mix of decimals attribute values: -6 -3. Element us-gaap_ProceedsFromSaleOfOtherProductiveAssets had a mix of decimals attribute values: -4 0. Element us-gaap_ResearchAndDevelopmentExpense had a mix of decimals attribute values: -3 0. Element us-gaap_RoyaltyRevenue had a mix of decimals attribute values: -3 0. Element us-gaap_StockIssued1 had a mix of decimals attribute values: -3 0. Element us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans had a mix of decimals attribute values: -3 0. Element us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised had a mix of decimals attribute values: -3 0. 'Monetary' elements on report '4050 - Disclosure - Acquisition of Astex Therapeutics Limited (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '4090 - Disclosure - Montigen Pharmaceuticals Acquisition (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '4100 - Disclosure - Nipent Sale Transactions (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '4120 - Disclosure - Commitments and Contingencies (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '4121 - Disclosure - Commitments and Contingencies (Details 2)' had a mix of different decimal attribute values. Process Flow-Through: 0010 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: 0015 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 0020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2011' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2011' Process Flow-Through: 0030 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2011' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2011' Process Flow-Through: 0050 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS astx-20121231.xml astx-20121231.xsd astx-20121231_cal.xml astx-20121231_def.xml astx-20121231_lab.xml astx-20121231_pre.xml true true